Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2013

View Archived Issues

Novel TSPO PET radioligand described with low sensitivity to human genotypes

Janssen Research & Development joins MMRF's pre-competitive consortium for multiple myeloma

Results presented for clinical study of macimorelin in the treatment of cancer cachexia

InSite Vision regains rights to AzaSite Xtra

Luoxis Diagnostics reports results from first study of its proprietary diagnostic platform

Shield Therapeutics completes phase III enrollment for ST-10 in iron-deficient anemia

Tanzisertib proves to be well tolerated in vivo but clinical results lead to discontinuation

Phase II data reported for etrolizumab in ulcerative colitis

Results of a phase II study of brodalumab for asthma presented

A novel potent LPL activator improves plasma lipid levels in vivo

Researchers from Korea present phase II data for lobeglitazone

ACIP recommends Flublok influenza vaccine for adults with egg allergy

Anthera Pharmaceuticals begins phase II BRIGHT-SC study in IgA nephropathy

AtheroNova begins phase I study of AHRO-001

National Eye Institute supports stem cell research for patients with corneal blindness

FDA grants fast track designation to RBX-2660

Phase II results for C-Cure in heart failure reported, phase III study advances

Verona Pharma doses first patient in VRP-700 trial

DiaMedica provides update on DM-199 program for type 2 diabetes

Bristol-Myers Squibb patents new MGAT2 inhibitors

Novel opsin protein ligands designed by BIKAM Pharmaceuticals

Avanir's Nuedexta approved by the European Commission for pseudobulbar affect

Roche synthesizes novel BTK inhibitors

FDA approves pediatric indication for Mycamine

Basilea awarded BARDA contract for novel antibiotic

Researchers at Novartis divulge novel androgen receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...